Intelligence · Clinical pipeline
Oncology R&D Pipeline
Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Quick answer
Oncology: NovaPharmaNews indexes 5,539 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Top sponsors
- First People's Hospital 474 programs
- Chinese Academy of 400 programs
- United Therapeutics Europe 219 programs
- George Institute for 172 programs
- Takeda 163 programs
- HOFFMANN-LA ROCHE 144 programs
- AstraZeneca 143 programs
- MSD Merck Sharp 131 programs
- Regeneron UK 128 programs
- Anaxis Pharma 125 programs
- Telethon Foundation 113 programs
- Novartis India 110 programs
Pipeline programs
-
Zanidatamab
Jazz Pharmaceuticals Ireland Limited
Non-Small Cell Lung Cancer
1 trial -
Zanidatamab
Jazz Pharmaceuticals Ireland Limited
Breast Cancer
1 trial -
Zanidatamab
Jazz Pharmaceuticals Ireland Limited
Gastroesophageal Adenocarcinoma
1 trial -
Zanubrutinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mantle Cell Lymphoma
1 trial -
Zanubrutinib
The First People's Hospital of Lianyungang
Chronic Lymphocytic Leukemia
1 trial -
Zanubrutinib
BEONE MEDICINES AUS PTY LTD
Relapsed/Refractory Follicular Non-Hodgkin Lymphoma
1 trial -
Zanubrutinib
BEONE MEDICINES AUS PTY LTD
Follicular Lymphoma
1 trial -
Zanubrutinib
The First People's Hospital of Lianyungang
Non Hodgkin Lymphoma
1 trial -
Zanubrutinib
BEONE MEDICINES AUS PTY LTD
Relapsed Diffuse Large B-cell Lymphoma
1 trial -
Zanubrutinib
BEONE MEDICINES AUS PTY LTD
Mantle Cell Lymphoma
1 trial -
Zanubrutinib
BEONE MEDICINES AUS PTY LTD
Diffuse Large B-cell Lymphoma (DLBCL)
1 trial -
Zanubrutinib
BEONE MEDICINES AUS PTY LTD
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
1 trial -
Zanubrutinib
BEONE MEDICINES AUS PTY LTD
Chronic Lymphocytic Leukemia (CLL)
1 trial -
Zanubrutinib+Rituximab+Lenalidomide
The First People's Hospital of Lianyungang
Diffuse Large B Cell Lymphoma
1 trial -
Zelenectide Pevedotin, BT8009
BICYCLE THERAPEUTICS
Advanced or Metastatic Non-small Cell Lung Cancer
1 trial -
Zentalis
Zentalis Pharmaceuticals
Advanced Pancreatic Adenocarcinoma
1 trial -
Ziftomenib
Kura Oncology
Advanced Malignant Neoplasm
1 trial -
Ziftomenib, Ziftomenib
Kura Oncology
Relapsed and/or refractory Acute Myeloid Leukemia
1 trial -
Zilovertamab vedotin
Merck Sharp and Dohme
Hematologic Malignancies or Solid Tumors in Pediatric and Young Adults
1 trial -
Zimberelimab
Arcus Biosciences
Hepatobiliary Cancer
1 trial -
Zimberelimab
Arcus Biosciences
Adenocarcinoma Stomach
1 trial -
Zimberelimab
Arcus Biosciences
Pancreatic Ductal Adenocarcinoma
1 trial -
Zimberelimab
Arcus Biosciences
Melanoma
1 trial -
Zimberelimab (ZIM)
Arcus Biosciences
Lung Cancer
1 trial -
Zirconium Zr 89 Girentuximab
Telix Innovations
Clear Cell Renal Cell Carcinoma
1 trial -
Ziv-Aflibercept
Regeneron UK Limited
Uveal Melanoma
1 trial -
Zn-Telomir
Telomir Pharmaceuticals
Triple-Negative Breast Cancer (TNBC)
1 trial -
Zoladex
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Zumsemetinib
Aclaris Therapeutics
Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer
1 trial -
[177Lu]-NeoB solution for infusion, AAA503
Advanced Accelerator Applications
Solid tumors known to overexpress GRPR and with [68Ga]-NeoB lesion uptake.
1 trial -
[18F]Tetrafluoroborate
Disc Medicine
Differentiated Thyroid Cancer
1 trial -
[203Pb]Pb-PSV359
Perspective Therapeutics
Pancreatic Ductal Adenocarcinoma
1 trial -
[203Pb]VMT-α-NET
Perspective Therapeutics
Neuroendocrine Tumors Unresectable
1 trial -
[203Pb]VMT01
Perspective Therapeutics
Recurrent Melanoma (Skin)
1 trial -
[68Ga]BED003 injection
Blue Earth Diagnostics Ireland Ltd
Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).
1 trial -
abituzumab
United Therapeutics Europe Ltd
Metastatic Colorectal Cancer
1 trial -
aflibercept + FOLFIRI
Regeneron UK Limited
Metastatic Colorectal Cancer
1 trial -
aglatimagene besadenovec
Candel Therapeutics
Prostate Cancer
1 trial -
aglatimagene besadenovec + valacyclovir
Candel Therapeutics
Prostate Cancer Patients Treated by Radiotherapy
1 trial -
alisertib
Takeda
Malignant Rhabdoid Tumor
1 trial -
alpha 1H, Placebo product for Alpha1H
Lacuna Pharma Pty Ltd
Non-muscle invasive bladder cancer awaiting transurethral surgery
1 trial -
anastrozole
Atrium Therapeutics
Female Breast Carcinoma
1 trial -
anlotinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sarcoma, Soft Tissue
1 trial -
anlotinib
Fudan University
Extensive-stage Small Cell Lung Cancer
1 trial -
anlotinib +TQB2450 + Oxaliplatin+S-1
The First People's Hospital of Lianyungang
Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
1 trial -
anlotinib combined with penpulimab
The First People's Hospital of Lianyungang
Non-small Cell Lung Cancer
1 trial -
anlotinib+TQB2450+nab-paclitaxel+cisplatin
The First People's Hospital of Lianyungang
Advanced Biliary Tract Cancer
1 trial -
anti-BCMA CAR-T
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Plasma Cell Leukemia
1 trial
Frequently asked questions
How many oncology pipeline programs are tracked?
5,539 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.